IDIQ to Support the Advisory Committee on Heritable Disorders in Newborns and Children

The Health Resources and Services Administration (HRSA) issued solicitation 75R60220R00023 to establish an Indefinite Delivery, Indefinite Quantity (IDIQ) contract to support the Advisory Committee on Heritable Disorders in Newborns and Children. The primary purpose of this requirement is to assist the Committee in providing recommendations, advice, and technical information to the Secretary regarding technologies, policies, and standards for reducing morbidity and mortality in at-risk newborns and children. This support focuses on enhancing the capacity of state and local health agencies to provide screening, counseling, and healthcare services while facilitating systematic evidence-based recommendations for conditions considered for the Recommended Uniform Screening Panel (RUSP).

This procurement is classified under NAICS 541720 for Research and Development in the Social Sciences and Humanities and PSC B537 for Special Studies/Analysis- Medical/Health. Managed by the HRSA Office of Operations, the solicitation process included 14 attachments such as the revised statement of work, contract sections A through J, and vendor questions and answers. Biji John is the point of contact for this requirement.

The solicitation was published on July 30, 2020, and last updated on January 6, 2021. The deadline for responses was August 24, 2020. The scope of work involves evaluating screening methods and assessing conditions that have the potential to significantly impact public health.